Intech biopharm ltd
NettetView live INTECH BIOPHARM LTD chart to track its stock's price action. Find market predictions, 6461 financials and market news. NettetIntech Biopharm Ltd. operates as a drugs development company. The Company develops and sells bronchial asthma drugs, chronic obstructive pulmonary disease drugs, and …
Intech biopharm ltd
Did you know?
NettetIntech Biopharm General Information. Description. Intech Biopharm Ltd is a biotechnology company. The company develops inhalation products including single or combination generic products and some new combination or new formulation projects are under development. It develops drugs for the treatment of lung diseases such as asthma. NettetIntech Biopharm Ltd - Synmosa Group. Revenue. $5.2 M. Employees. 22. Founded. 2010. Primary Industries. Business Services Research & Development. Intech Biopharm Executive Team & Key Decision Makers. Name & Title Social Contact Info; Cheryl Lin. Director, Business Development
NettetIntech Biopharm. Ltd 益得生技 is a Pharmaceuticals, Drug Manufacturing & Research, and Drug Discovery company located in Taipei, TW with $5.00 Million in revenue and 23 employees. Find top employees, contact details and business statistics at RocketReach. NettetAddress：3F., No.36, Ln. 358, Ruiguang Rd., Dist., Taipei City 114, Taiwan E-Mail： [email protected] TEL：+886-2-7721-8877 FAX：+886-2-7721-8800 …
Nettet6461: Intech Biopharm Ltd Stock Price Quote - Taipei - Bloomberg Live Now Bloomberg TV+ Bloomberg Daybreak Middle East Bloomberg Daybreak Middle East. Live from Dubai, connecting Asian... Nettet14. feb. 2012 · Patents Assigned to Intech Biopharm Ltd. Method for preparing metered dose sprayed inhaler for treating respiratory disease Patent number: 9241904 Abstract: …
NettetAlso Known As Intech Biopharm. Ltd; Legal Name Intech Biopharm Corporation; Company Type For Profit; Contact Email [email protected]; Phone Number …
NettetSynmosa Biopharma Inks NT$210 million Licensing Agreement for Budesonide. 2016.05.09. Synmosa's Posts Highest Single-Quarter Earnings Ever, EPS Hits NT$1.35. 2016.05.03. Synmosa Signs NT$420 million Deal with Hemony Pharma. 2016.03.24. Synmosa Collaborates with InnoPharmax to Branch Out into Production of API. hays vet clinichttp://so.cnyes.com/stocksearch.aspx?q=galaxy+entertainment+group+ltd+adr&l=LB2&m=0&p=39 botw flowersNettetCash Flow Statement for Intech Biopharm Ltd, company's cash and cash equivalents, broken down to operating, investing and financing activities. botw flurry attackNettet2. feb. 2024 · Intech Biopharm focuses mainly on developing drugs for obstructive airway diseases such as bronchial asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2010 and is headquartered in New Taipei City. Headquarters 3F., No.36, Ln. 358, Ruiguang Rd., Taipei, Taiwan Taipei City; Taipei City; botw flurry rush glitchNettetIntech is focusing on the development and manufacturing of new drug combinations, new formulations and generic drugs with high entry barriers in the field of respirator … UNIQUE TECHNOLOGY PLATFORM Intech is focusing on the development an… Intech Biopharm Corporation © 2014 All Rights Reserved. 3F., No.36, Ln.358, R… haysville activity center summer elementsNettetDry Powder Inhaler, DPI. Intech owns the capability of DPI development and manufacturing. With the u001flling technology of blisters and capsules, these products combined with device are convenient to use and safe. More than that, the patented designed Pandahaler is popular and attractive. botw font downloadNettetIntech Biopharm Ltd. 2024-03-29. A Randomized, Single-dose, Open-label, Two-way Crossover Pivotal Study to Assess the Bioequivalence Between Albuterol Sulfate … haysville activity center hours